Hee Jung Son

Hee Jung Son

Auto-generated profile, based on publicly available information

Hee Jung Son

Affiliations Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, Center for Health Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in Atherosclerosis
Verified
Journal Article
Closed access
DSDong Hyun Sinn
Dong Hyun Sinn
GGGeum-Youn Gwak
Geum-Youn Gwak
JCJuhee Cho
Juhee Cho
HSHee Jung Son
Hee Jung Son
YPYong-Han Paik
Yong-Han Paik
BYByung Chul Yoo
Byung Chul Yoo

27 April 2011 in Digestion
Verified
Journal Article
Closed access
Hyuk LeeHyuk Lee
Hyuk Lee
BMByung-Hoon Min
Byung-Hoon Min
JLJun Haeng Lee
Jun Haeng Lee
HSHee Jung Son
Hee Jung Son
JKJae J. Kim
Jae J. Kim
PRPoong-Lyul Rhee
Poong-Lyul Rhee
Background/Aims: Early gastric cancer (EGC) can be treated by endoscopic resection, which results in an excellent prognosis. Optimal screening intervals considering risk factors for gastric cancer have not been established. The aim of this study was to determine the maximum gastric cancer screening interval in terms of long-term survival. Methods: Curative resection was performed in 561 patients with gastric cancer who had completed a questionnaire on their previous history of screening tests and risk factors. The association between EGC detection rate and previous screening history was evaluated, and 5-year disease-free survival rates were compared between various screening intervals. Results: Multivariate analysis showed that intestinal metaplasia [hazard ratio (HR) 9.690, 95% confidence interval (CI) 5.896–15.927] and previous screening history (HR 0.077, 95% CI 0.048–0.125) were independent factors associated with advanced gastric cancer. In patients without intestinal metaplasia, there was no significant difference in the extent of gastric cancer progression and the 5-year disease-free survival rate between groups with screening intervals of less than 3 years. In patients with intestinal metaplasia, the cutoff screening interval for detection of EGC and disease-free survival was 2 years. Conclusion: The optimum screening interval for disease-free survival for gastric cancer in a normal population is 3 years, but a screening interval of 2 years should be used for patients with intestinal metaplasia in Korea.

1 September 2020 in The Korean Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
YMYang Won Min
Yang Won Min
YLYeong Chan Lee
Yeong Chan Lee
KKKyunga Kim
Kyunga Kim
SRSeungho Ryu
Seungho Ryu
KHKyoung Sub Hong
Kyoung Sub Hong
PRPoong-Lyul Rhee
Poong-Lyul Rhee
Effect of proton pump inhibitor (PPI) use on the risk of hip fracture is controversial. This study aimed to clarify the association between PPI use and hip fracture risk using a large cohort. This study recruited participants from the nationwide cohort (n = 1,025,340). After exclusion of participants who had hip fractures or were aged less than 40 years during the baseline period (2002 to 2004), 371,806 participants were followed to 2013. Participants prescribed PPIs for more than 90 days during baseline period were defined as users. Fracture cases were defined when participants were hospitalized with claims of a hip fracture. During 4,159,343 person-years of follow-up, fractures developed more often in PPI users than in nonusers (relative risk [RR], 1.787; 95% confidence interval [CI], 1.260 to 2.534; p = 0.002). The results persisted after adjusting for age, sex, and many drugs relevant to osteoporosis or influential in bone health. Furthermore, fracture risk associated with PPI use increased with duration of use (p trend < 0.001). The fully adjusted RRs of hip fracture development were 1.350 (95% CI, 1.203 to 1.515) for 1- to 90-day users, 1.487 (95% CI, 0.957 to 2.311) for 91- to 180-day users, and 1.771 (95% CI, 0.931 to 3.368) for > 180-day users. The positive association between PPI use and fracture was also confirmed in a subgroup with health screening data where further adjustment for body mass index, smoking status, alcohol consumption, and physical activity was available (adjusted RR, 2.025; 95% CI, 1.151 to 3.564, p = 0.014). PPI use is associated with hip fracture development.

29 December 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YLYeong Chan Lee
Yeong Chan Lee
TKTae Jun Kim
Tae Jun Kim
JKJong-Hun Kim
Jong-Hun Kim
ELEunjin Lee
Eunjin Lee
WPWoong-Yang Park
Woong-Yang Park
HSHee Jung Son
Hee Jung Son
Inflammatory bowel disease (IBD) is an idiopathic inflammatory disorder characterized by chronic and relapsing manifestations. Several environmental factors are known as triggers for exacerbation of IBD. However, an association between exacerbation of IBD and ambient temperature is uncertain. This study aimed to estimate the risk of acute exacerbation of IBD due to ambient temperature. We performed a bidirectional case-crossover study using a nationwide claim data from South Korea. The external validation was conducted with a large prospective cohort in the United Kingdom. We confirmed significant associations between acute exacerbation of IBD and the short-term ambient temperature changes toward severe temperatures, in the cold weather (-19.4°C–4.3°C) (odd ratio [OR] = 1.13, 95% confidence interval [CI]: 1.13–1.14) and in the hot weather (21.3°C–33.5°C) (OR = 1.16, 95% CI: 1.15–1.17). However, the association was not significant in the moderate weather (4.3°C–21.3°C). The external validation suggested consistent results with additional elevation of acute exacerbation risk in the colder weather (-13.4°C to 2.6°C) (OR = 1.90, 95% CI: 1.62–2.22) and in the hotter weather (15.7°C–28.4°C) (OR = 1.41, 95% CI: 1.32–1.51). We observed and validated that the short-term ambient temperature changes were associated with acute exacerbation of IBD in the cold and hot weathers. Our findings provide evidence that temperature changes are associated with the acute exacerbation of IBD.